Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Sponsors » Genomics: Clinical Implementation » Foundation Medicine Positions Blood-Based TMB Test as Companion Dx to First-Line Immunotherapy

Foundation Medicine Positions Blood-Based TMB Test as Companion Dx to First-Line Immunotherapy

Sep 12, 2017
|
Molika Ashford
Premium

NEW YORK (GenomeWeb) – Foundation Medicine said last week that it is advancing a blood-based version of its tumor mutational burden test as a companion diagnostic to Roche/Genentech’s immunotherapy drug Tecentriq (atezolizumab) in first-line treatment of non-small cell lung cancer patients.

The assay is moving forward in two clinical trials. In a single-arm trial called B-F1RST, investigators are retrospectively analyzing blood-based TMB status in NSCLC patients treated with first-line Tecentriq regardless of their biomarker status.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

HIV Found in Old Tissue Sample

A tissue sample from the 1960s harbors a near-complete sample of HIV, IFLScience reports.

A New NSF?

A new bill would reshape the US National Science Foundation to include a focus on technological development, according to Science.

Stopped It

The Food and Drug Administration's decision to halt a SARS-CoV-2 study has drawn criticism, according to Stat News.

Genome Biology Papers on Parasite Impacts in Gut, Lung Microenvironment Interactions, More

In Genome Biology this week: features affecting gut microbiome and parasite patterns, cellular interactions in lung tumor microenvironment, and more.

Jun
02
Featured Webinar

The Need for Digital Spatial Profiling for Host-Pathogen Interaction: A York Perspective

Sponsored by
NanoString

Core facilities support a broad range of scientific studies and must constantly integrate new technologies and analysis to underpin their users’ research. Areas for development include higher multiplex capabilities, greater quantification, correlation to other tools, as well as multi-omics. 

Jun
04
Featured Webinar

COVID-19 Testing, Treatment and Future Outlook

Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
09
Featured Webinar

Our Magic DRAGEN: A Sequencing Lab Case Study on Accelerated Bioinformatics

Sponsored by
Illumina

In this webinar, Dr. Charlie Johnson, founder of the Texas A&M AgriLife Genomics and Bioinformatics Service, will share how his team is utilizing Illumina’s DRAGEN informatics platform in its high-throughput agrigenomics research program. 

What's Popular?

In Sequencing

  1. Chan Zuckerberg Initiative Awards $3.8M in Grants for Open-Source Biomedical Software Projects

  2. GnomAD Consortium Details Range of Human Genetic Variation From Large Dataset

  3. WUSTL-led Team Compiles Human Structural Variant Resource

  4. NantOmics Shuts Down Genos Direct-to-Consumer Genomics Services

  5. John Theurer Cancer Center, Genomic Testing Cooperative to Establish NGS Lab for Cancers

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.